An Act to amend the Code of Virginia by adding in Chapter 2 of Title 32.1 an article numbered 22.1, consisting of a section numbered 32.1-73.27:1, relating to Sickle Cell Coordinated Access Network established; report.
HB1391 establishes a Sickle Cell Coordinated Access Network within the Virginia Department of Health structure, to be maintained by the State Health Commissioner in collaboration with the Virginia Commonwealth University Health Systems Authority. The network is intended to give health care providers across the Commonwealth real-time access to sickle cell specialists for telehealth consultation and support, especially for extended coverage. Participating specialists would provide guidance on pain management, consultation on treatment protocols, and coordination of care for patients with sickle cell trait or sickle cell disease.
The bill also directs the State Health Commissioner, working with the Secretary of Health and Human Resources, VCU Health System, and other stakeholders, to develop recommendations on how the network should be established and maintained. Those recommendations must be reported to specified House and Senate committee chairs by December 1, 2026. The operative provisions of the act become effective July 1, 2027.
The bill adds a new article to Title 32.1 of the Code of Virginia, creating a formal state framework for sickle cell specialist consultation and care coordination. It does not directly create a new benefit program or mandate treatment coverage, but it does require the Commissioner to establish and maintain a statewide network and to develop implementation recommendations. The measure primarily affects the State Health Commissioner, VCU Health System, health care providers, and patients with sickle cell trait or sickle cell disease, with the goal of improving access to specialized expertise and telehealth support.
The bill appears to have been enacted without recorded controversy in the available materials, and the final status indicates it was approved as Chapter 838. The overall sentiment is best characterized as supportive of improving care for people with sickle cell disease by expanding access to specialist consultation and care coordination. Because there are no committee transcripts or recorded votes provided, there is no evidence in the record of organized opposition or divided sentiment.
No notable points of contention are reflected in the provided legislative history. The main policy questions implied by the bill are operational rather than ideological: how the network will be structured, how extended telehealth coverage will work, what resources will be needed, and how responsibilities will be shared among the Commissioner, VCU Health System, and other stakeholders. Any concerns would likely center on implementation, funding, and provider availability, but none are documented in the materials provided.